DiMe

At Healthcare 2030 in Washington, D.C., panelists highlighted debated challenges around interoperability, FHIR adoption and the need for industry-wide standards.

At an event in Washington, D.C., on Monday, DiMe released a thesis with what it says are four impact areas that are vital to pursue in digital medicine in the next five years.

The course aims to help doctors, researchers and healthcare professionals learn about generative AI and LLMs and how the technology is used in healthcare.

The collaboration aims to delineate best practices to help streamline the path to commercialization for digital health products.

The Digital Medicine Society partnered with digital health and pharma players like the FDA, Janssen, GSK, Medable and THREAD to build a toolkit aimed at improving diversity in digital research.

The toolkits are based on the Digital Medicine Society's Sensor Data Integrations project, which includes organizations like Amazon Web Services, Oracle, the Moffitt Cancer Center, Takeda and the U.S. Department of Veterans Affairs.

The partnership, which includes Anthem, Biogen, Eli Lilly, Evidation, Janssen and Merck, gives payers guidance for including digital endpoints in reimbursement for new drugs.

Also, Northern Ireland partners with Sectra to digitise pathology.